NicoleYunMD

PubMed

• 3 citations
  Transfusion Independence Achieved with Combination Fedratinib and Luspatercept in an Elderly Man with Heavily Pretreated Intermediate-2 Risk Primary Myelofibrosis.
  Nicole K Yun, Taha Alrifai, Ira J Miller, Jamile M Shammo
  Case Reports in Oncology. 2022-02-14
• 7 citations
  Concordance of breast cancer biomarker testing in core needle biopsy and surgical specimens: A single institution experience.
  Jessica A Slostad, Nicole K Yun, Aimee E Schad, Surbhi Warrior, Louis F Fogg
  Cancer Medicine. 2022-12-01
• 17 citations
  Neutrophil-to-Lymphocyte Ratio Is a Predictive Biomarker in Patients with Epidermal Growth Factor Receptor (EGFR) Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) T...
  Nicole K. Yun, Sherin J. Rouhani, Christine M. Bestvina, Ethan M. Ritz, Brendan A. Gilmore
  Cancers. 2021-03-20

Abstracts/Posters

• Clinical Activity of Sacituzumab Govitecan in Metastatic Triple Negative and Hormone Receptor Positive, HER-2 Negative Breast Cancer
  Nicole Yun, MD, Laura Owczarzak, MD, Koosha Paydary, MD, Trevor Christ, PharmD, BCOP, Ruta Rao, MD, San Antonio Breast Cancer Symposium 2024, San Antonio, Texas, 12/12/2024
• A Prospective Trial of Serum Folate Levels in Women with Solid Tumor Malignancies Treated with Olaparib
  Laura Owczarzak, MD, Nicole K Yun, MD, Lois Winkelman, RNMS, AOCN, CCRC, Jamile Shammo, MD, Lydia Usha, MD, Blood November 2024 Supplemental Issue, 11/2024
• Neutrophil to Lymphocyte Ratio Is Associated With Mortality in Patients Undergoing Treatment for Hemato-oncologic Malignancies and Admitted for COVID 19
  C.J. Wakefield, N. Yun, J. Borgia, A. Varma, C.W. Seder, T.M. Kuzel, American Thoracic Society International Conference, Washington, D.C., 5/22/2023
• RNA Sequencing to Characterize Pathways in EGFR-mutated Non-Small Cell Lung Cancer
  Nicole Yun, MD, Ankur Naqib, PhD, Jeffrey A Borgia, PhD, Mary Jo Fidler, MD, IASCL 2022 World Conference on Lung Cancer, Vienne, Austria, 8/6/2022
• RNA Sequencing to Characterize Pathways in EGFR-mutated Non-Small Cell Lung Cancer
  Nicole Yun, Ankur Naqib, Michael Jelinek, Jeffrey Borgia, Mary Jo Fidler, IASCL 2022 Targeted Therapies of Lung Cancer Meeting, 2/24/2022
• Four-Fold Increased Mortality from Sars-Cov-2 Infection in Patients with Hematologic Versus Non-Hematologic Malignancies Treated at the Largest Tertiary COVID-19 Cente...
  Nicole K. Yun, Praneeth Chebrolu, Paul R. Yarnold, Joshua Thomas, James L. Coggan, Anmol Baranwal, Charles L. Bennett, Ankur Varma, Timothy M. Kuzel, American Society of Hematology 63rd Annual Meeting and Exposition, Atlanta, GA, 12/11/2021
• Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic
  Shivani Rao, Nicole K. Yun, James L. Coggan, Peter Wu, Teresa O'Brien, Katherine Barnett, Sean O'Mahony, Ramandeep Kaur, Christopher Bruti, Celine Goetz, Jerome J Mart..., Blood (2021) 138 (Supplement 1): 4178, 11/23/2021
• Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19
  Shivani Rao, Nicole K. Yun, James L. Coggan, Peter Wu, Teresa O'Brien, Katherine Barnett, Sean O'Mahony, Ramandeep Kaur, Christopher Bruti, Celine Goetz, Jerome J Mart..., Blood (2021) 138 (Supplement 1): 4179., 11/23/2021
• Psychosocial Distress in Patients with Driver-Mutant Lung Cancer
  Lia Head, Nicole Yun, Sanjib Basu, Lauren Rynar, Jill Feldman, Marta Batus, Phillip Bonomi, Michael Jelinek, Mary Jo Fidler, IASLC 2021 World Conference on Lung Cancer, Denver, Colorado, 9/9/2021
• Psychosocial distress in patients with driver-mutant lung cancer
  Lia Head, Nicole Yun, Sanjib Basu, Lauren Rynar, Jill Elizabeth Feldman, Marta Batus, Philip D. Bonomi, Michael J. Jelinek, Mary J. Fidler, J Clin Oncol 39, 2021 (suppl 15; abstr e24125), 6/4/2021
• Hematology Referral for Intravenous Iron Replacement Therapy Reduces Number of Emergency Room Visits or Hospitalizations in Patients with Symptomatic Iron Deficiency A...
  Nicole K Yun MD, Revathi Kollipara MD, Benjamin D German MD, Sarah K Swanson, Ethan M Ritz MS, Jamile M Shammo MD, 2021 ACP National Abstract Competition Poster Finalist, 5/3/2021
• The Neutrophil-to-Lymphocyte Ratio is a Prognostic Biomarker in Patients with EGFR Mutated Advanced NSCLC
  S. Rouhani, N. Yun, C. Bestvina, B. Gilmore, E. Ritz, I. Tarhoni, M. Batus, J. Borgia, P. Bonomi, M.J. Fidler, Journal of Thoracic Oncology, 3/1/2021
• Concordance of breast cancer biomarker testing in core-needle biopsy and surgical specimens: a single institution experience
  Jessica Slostad, MD, Nicole Yun, MD, Aimee Schad, MD, Surbhi Warrior, MD, Ruta Rao, MD, 2020 San Antonio Breast Cancer Symposium (SABCS), Virtual Symposium San Antonio, Texas, 12/8/2020
• Myeloproliferative Neoplasms with Co-occurrence of Lymphoid and/or Plasma Cell Neoplasms: A Retrospective Clinicopathologic Review
  Josean Ramos, Nicole K Yun, Jamile Shammo, Ira Miller, Karina Furlan, College of American Pathologists 2020 Virtual Meeting, 10/10/2020
• The prognostic value of neutrophil-to-lymphocyte ratio in patients with epidermal growth factor receptor mutated advanced non-small cell lung cancer (NSCLC)
  Nicole Yun, Sherin Juliet Rouhani, Brendan Gilmore, Ethan M. Ritz, Christine M. Bestvina, Imad Tarhoni, Marta Batus, Jeffrey Allen Borgia, Philip D. Bonomi, Mary J. Fi..., J Clin Oncol 38: 2020 (suppl; abstr e21675), 5/13/2020
• Neutrophil-to-Lymphocyte Ratio as an Early Marker of Outcomes in Patients with Epidermal Growth Factor Receptor Mutation Positive Advanced Non-Small Cell Lung Cancer
  Brendan Gilmore MD, Nicole Yun MD, Imad Tarhoni MD, Marta Batus MD, Jeffrey A. Borgia PhD, Philip Bonomi MD, Mary Jo Fidler MD, 1st Annual EGFR Resisters Research Summit, Chicago, IL, 11/15/2019
• Join now to see all

Lectures

• RNA Sequencing to Characterize Pathways in EGFR-mutated Non-Small Cell Lung Cancer 
  3rd Annual EGFR Resisters Research Summit - 11/14/2021